# Safety and Efficacy of Autologous SVF Cells in Treating Patients With Osteoarthritis

> **NCT02846675** · PHASE1,PHASE2 · COMPLETED · sponsor: **Shanghai East Hospital** · enrollment: 50 (actual)

## Conditions studied

- Osteoarthritis

## Interventions

- **BIOLOGICAL:** autologous SVF
- **BIOLOGICAL:** Placebo

## Key facts

- **NCT ID:** NCT02846675
- **Lead sponsor:** Shanghai East Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-11-01
- **Primary completion:** 2017-07-31
- **Final completion:** 2018-01-31
- **Target enrollment:** 50 (ACTUAL)
- **Last updated:** 2018-09-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02846675

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02846675, "Safety and Efficacy of Autologous SVF Cells in Treating Patients With Osteoarthritis". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT02846675. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*